Peer review reports
From: miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
Original Submission | ||
---|---|---|
19 Jul 2019 | Submitted | Original manuscript |
22 Aug 2019 | Reviewed | Reviewer Report - XIAOMIN YING |
30 Aug 2019 | Reviewed | Reviewer Report - Hualong Yan |
4 Sep 2019 | Reviewed | Reviewer Report - Bushra Ateeq |
5 Nov 2019 | Author responded | Author comments - Peng Ge |
Resubmission - Version 2 | ||
5 Nov 2019 | Submitted | Manuscript version 2 |
13 Nov 2019 | Reviewed | Reviewer Report - Hualong Yan |
22 Nov 2019 | Author responded | Author comments - Peng Ge |
22 Nov 2019 | Reviewed | Reviewer Report - XIAOMIN YING |
Resubmission - Version 3 | ||
22 Nov 2019 | Submitted | Manuscript version 3 |
28 Nov 2019 | Author responded | Author comments - Peng Ge |
Resubmission - Version 4 | ||
28 Nov 2019 | Submitted | Manuscript version 4 |
Publishing | ||
29 Nov 2019 | Editorially accepted | |
10 Dec 2019 | Article published | 10.1186/s12885-019-6416-4 |